Singular Health Group Ltd. Q1 FY2026 Activities Report
Key points
- Continued commercial advancement in U.S. with Triple-S and PNS
- Successful deployment of 3DICOM in Florida and M-DCPS
- Maintained compliance with ISO 27001, HIPAA, and SOC 2 Type II
- Strong cash position of $10.1 million
- Progressed national phase patent filings for MFTP technology
Full summary
Singular Health Group Ltd. (ASX: SHG) announced key developments for the quarter ended June 30, 2026. The company engaged in final discussions with Triple-S in Puerto Rico and continued successful negotiations with PNS for contract renewal. Deployments in Florida and Miami-Dade County Public Schools (M-DCPS) were completed, and compliance with ISO 27001, HIPAA, and SOC 2 Type II was maintained. Patent filings for the Medical File Transfer Protocol (MFTP) technology progressed, and the company reported a strong cash position of $10.1 million, providing a runway of close to two years.
Guidance
Strong cash position of $10.1 million, providing a funding runway of close to two years
Outlook
Singular Health expects continued progress across its U.S. commercial opportunities, including finalizing discussions with Triple-S, expanding pilot deployments, and advancing the Florida Statewide Imaging Repository project.
Summary generated by a large language model. Please interpret with care.